about
Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity.Oxidative metabolism of ferrocene analogues of tamoxifen: characterization and antiproliferative activities of the metabolites.Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation.Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.Ferrocifen derivatives that induce senescence in cancer cells: selected examples.Atypical McMurry cross-coupling reactions leading to a new series of potent antiproliferative compounds bearing the key [ferrocenyl-ene-phenol] motif.The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells.Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: cancer cell growth inhibition, ROS production and hemolytic activity.Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells.Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines.Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.Effect of the amino chain length and the transformation into citric acid salts of aryl-diphenyl-butenes and ferrocenyl-diphenyl-butenes bearing two dimethylaminoalkyl chains on their antimicrobial activities.Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin.Enzymatic oxidation of ansa-ferrocifen leads to strong and selective thioredoxin reductase inhibition in vitro.Molecular mechanism of action of 2-ferrocenyl-1,1-diphenylbut-1-ene on HL-60 leukemia cells.A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.Aryl butenes active against K562 cells and lacking tyrosinase inhibitory activity as new leads in the treatment of leukemia.Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.Antibacterial properties and mode of action of new triaryl butene citrate compounds.Antiparasitic and immunomodulatory activities of 1,1-bis(4-hydroxyphenyl)-2-phenyl-but-1-ene and its protected and free 2-ferrocenyl derivativesOxidative Sequence of a Ruthenocene-Based Anticancer Drug Candidate in a Basic EnvironmentThe replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cellsElectrochemical attachment of a conjugated amino–ferrocifen complex onto carbon and metal surfacesAnticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivativesEfficacy of a novel ferrocenyl diaryl butene citrate compound as a biocide for preventing healthcare-associated infectionsThe length of the bridging chain in ansa-metallocenes influences their antiproliferative activity against triple negative breast cancer cells (TNBC)Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer CellsFerrocenyl flavonoid-induced morphological modifications of endothelial cells and cytotoxicity against B16 murine melanoma cellsSynthesis and Antiproliferative Effects of [3]Ferrocenophane Transposition Products and Pinacols Obtained from McMurry Cross-Coupling Reactions
P50
Q30978260-CD0A5B5F-53E5-4E26-BEEE-8C9CC5B00D60Q35604815-F92D8BBC-2714-4AE1-B716-9E8B3792EAA9Q36045117-108FC23F-D3C6-42D5-B78E-2886FBCEB6B5Q36450311-50DC1F35-D360-47B1-847B-0673D2325746Q38952792-4285A0E5-A1F2-4DDB-9D9D-8F08C22FB847Q38974390-296793CD-E194-4652-8080-20E0B6A54856Q39137899-A52FCE1D-949B-4890-90F6-8F32DC6ED95EQ39346477-31F10D86-0E1E-42F9-AC6D-618A8389AC8CQ39520113-515F4192-75E5-4272-91F4-83E062710CA0Q39643708-960332E5-A1A1-48D8-869C-1DA1F48D81D5Q39761075-C6B7A2E7-72CF-4E83-8D2A-A496E3D6E1A3Q39815615-095BDB06-15B9-47DB-A351-7252AA5F36B0Q39837872-84B43935-C339-44F6-AE22-3AC194B83AC2Q39909413-10884A22-D01C-4CB5-A8E4-A243512516EFQ39967948-29E9DEAA-8E2B-4175-89A4-4BEC6074D9E6Q40054183-4FAFE8D6-43F5-4C22-B688-BF8D60E845E2Q40104107-0FCDADDC-1366-4E60-8EFD-B867D2717C53Q40412390-1417D653-B483-46E3-99D5-774FAEBD66DFQ40435765-13607099-FFDF-4E94-8087-1E23A7C1C93CQ40490612-A7F3B8D3-9189-4FC8-8699-BC528747A971Q41829975-871A25E7-A02F-47FE-8A55-B9F5036972ECQ45997848-C1CD925E-389E-4293-8FA1-32D5E1749E78Q46308420-5B7926E7-87C2-4E6A-BEFF-8E00FDE4F40BQ46496451-D133CDFE-D8F6-41B0-A659-FB92BA0CA33FQ51060992-D2BF8CD3-F4FC-4800-84F3-C5B9C7879CE4Q52599610-3ED98536-89A5-4B72-B81B-5613520696F3Q53424633-94148ED1-647C-43DF-94EC-331EE2F07554Q53738897-F465CC64-E1D4-4484-89DB-9274612927D7Q53745075-DD2414B2-9A94-4176-B213-D62E2ED864D3Q54293725-053D9E3B-9AB7-4EA3-A982-2B8E7874B57DQ57033916-40F5BC14-7747-4FA8-90CF-3B7CDF540E61Q57391543-15DB2AE0-DEA9-4CE9-9B54-99F90CC78CA0Q57391634-60A4E0F5-79B6-4563-AD02-E1DA090F9103Q57391639-23B71062-F780-44AA-A070-EABCA5E98F03Q58868507-5334F22C-21AA-4109-8E2D-807F6E0C7651Q60453027-C720EA32-7592-485A-9EC0-8D83FE9ED116Q60453028-026BF7D5-B5CA-479C-8B37-966451797B31Q60453029-F867A075-4490-4D6A-BD2B-78F90CACE3DFQ60453032-6567A446-8E87-4A1E-AF8D-221EBBADE5D6Q60453039-E91C4129-8B90-4C5E-BBBC-F398BBACFB75
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pascal Pigeon
@ast
Pascal Pigeon
@en
Pascal Pigeon
@es
Pascal Pigeon
@nl
Pascal Pigeon
@sl
type
label
Pascal Pigeon
@ast
Pascal Pigeon
@en
Pascal Pigeon
@es
Pascal Pigeon
@nl
Pascal Pigeon
@sl
prefLabel
Pascal Pigeon
@ast
Pascal Pigeon
@en
Pascal Pigeon
@es
Pascal Pigeon
@nl
Pascal Pigeon
@sl
P1053
F-9758-2014
P106
P108
P1960
JA7gN3sAAAAJ
P2038
Pascal_Pigeon
P21
P31
P3829
P496
0000-0001-5374-5346